meddevicedb.com FDA Device Reference

Endura™ Ureteral Stent and Stent Set

K251469 Class II Traditional
Decision Date
2025-12-19
Sponsor / Applicant
Cathegenix (Xiamen) Co., Ltd.

Technical Specification

510(k) Submission ID K251469
Product Code FAD
Medical Specialty / Panel Gastroenterology, Urology
Regulation Citation 21 CFR 876.4620
Decision Date 2025-12-19
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

Endura™ Ureteral Stent and Stent Set received FDA 510(k) clearance under submission number K251469, sponsored by Cathegenix (Xiamen) Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 2025-12-19.

Classification & Regulation

This clearance is catalogued under FDA product code FAD and 21 CFR 876.4620, within the Gastroenterology, Urology review panel as a Class II device.